Factors affecting the deposition of inhaled porous drug particles
CJ Musante, JD Schroeter, JA Rosati… - Journal of …, 2002 - Elsevier
Recent findings indicate that the inhalation of large manufactured porous particles may be
particularly effective for drug delivery. In this study, a mathematical model was employed to …
particularly effective for drug delivery. In this study, a mathematical model was employed to …
Efficient generation and selection of virtual populations in quantitative systems pharmacology models
Quantitative systems pharmacology models mechanistically describe a biological system
and the effect of drug treatment on system behavior. Because these models rarely are …
and the effect of drug treatment on system behavior. Because these models rarely are …
A prototype QSP model of the immune response to SARS‐CoV‐2 for community development
The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) pandemic requires
the rapid development of efficacious treatments for patients with life‐threatening coronavirus …
the rapid development of efficacious treatments for patients with life‐threatening coronavirus …
Lung models: strengths and limitations.
TB Martonen, CJ Musante, RA Segal… - Respiratory …, 2000 - europepmc.org
The most widely used particle dosimetry models are those proposed by the National Council
on Radiation Protection, International Commission for Radiological Protection, and the …
on Radiation Protection, International Commission for Radiological Protection, and the …
Hygroscopic growth and deposition of inhaled secondary cigarette smoke in human nasal pathways
JD Schroeter, CJ Musante, D Hwang… - Aerosol Science & …, 2001 - Taylor & Francis
<p>To ascertain the threat to human health posed by the inhalation of the particulate phase
for secondary cigarette smoke (SCS), it is necessary to determine the doses delivered to …
for secondary cigarette smoke (SCS), it is necessary to determine the doses delivered to …
Improving the generation and selection of virtual populations in quantitative systems pharmacology models
…, RD White, RA Everett, HT Banks, CJ Musante - Progress in biophysics …, 2018 - Elsevier
Quantitative systems pharmacology (QSP) models aim to describe mechanistically the
pathophysiology of disease and predict the effects of therapies on that disease. For most drug …
pathophysiology of disease and predict the effects of therapies on that disease. For most drug …
Predicting left ventricular contractile function via Gaussian process emulation in aortic-banded rats
Cardiac contraction is the result of integrated cellular, tissue and organ function. Biophysical
in silico cardiac models offer a systematic approach for studying these multi-scale …
in silico cardiac models offer a systematic approach for studying these multi-scale …
[HTML][HTML] PF-05231023, a long-acting FGF21 analogue, decreases body weight by reduction of food intake in non-human primates
…, Y Zhou, S Talukdar, CJ Musante - … of pharmacokinetics and …, 2016 - Springer
PF-05231023, a long-acting FGF21 analogue, is a promising potential pharmacotherapy for
the treatment of obesity and associated comorbidities. Previous studies have shown the …
the treatment of obesity and associated comorbidities. Previous studies have shown the …
FDA-Industry Scientific Exchange on assessing quantitative systems pharmacology models in clinical drug development: a meeting report, summary of challenges …
…, PH van der Graaf, R Madabushi, CJ Musante… - The AAPS Journal, 2021 - Springer
The pharmaceutical industry is actively applying quantitative systems pharmacology (QSP)
to make internal decisions and guide drug development. To facilitate the eventual …
to make internal decisions and guide drug development. To facilitate the eventual …
Mechanistic systems modeling to guide drug discovery and development
BJ Schmidt, JA Papin, CJ Musante - Drug discovery today, 2013 - Elsevier
A crucial question that must be addressed in the drug development process is whether the
proposed therapeutic target will yield the desired effect in the clinical population. …
proposed therapeutic target will yield the desired effect in the clinical population. …